Invesco Ltd. Moderna, Inc. Transaction History

Invesco Ltd.

$453 Billion
Q1 2024

A detailed history of Invesco Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 2,769,922 shares of MRNA stock, worth $329 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,769,922

Previous 2,909,609 4.8%

Holding current value

$329 Million

Previous $289 Million 2.01%

% of portfolio

0.07%

Previous 0.07%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $11.9 Million - $16.1 Million	-139,687 Reduced 4.8%	2,769,922 $295 Million
Q4 2023 Feb 12, 2024	SELL	$69.51 - $104.43 $15 Million - $22.6 Million	-216,419 Reduced 6.92%	2,909,609 $289 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $49.9 Million - $65.5 Million	517,683 Added 19.85%	3,126,028 $323 Million
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $34.6 Million - $46.9 Million	291,912 Added 12.6%	2,608,345 $317 Million
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $77.9 Million - $113 Million	574,362 Added 32.97%	2,316,433 $356 Million

Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $1.79 Million - $3.18 Million	15,134 Added 0.88%	1,742,071 $313 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $12.2 Million - $20.1 Million	-103,284 Reduced 5.64%	1,726,937 $204 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $34.9 Million - $52.6 Million	-298,031 Reduced 14.0%	1,830,221 $261 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $47 Million - $87.3 Million	371,311 Added 21.13%	2,128,252 $367 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $206 Million - $337 Million	914,343 Added 108.51%	1,756,941 $446 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $62 Million - $135 Million	279,271 Added 49.58%	842,598 $324 Million
Q2 2021 Aug 17, 2021	BUY	$129.91 - $234.98 $20.9 Million - $37.8 Million	160,809 Added 39.95%	563,327 $132 Million
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $8.26 Million - $14.1 Million	-75,659 Reduced 15.82%	402,518 $52.7 Million
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $13.9 Million - $35.9 Million	-211,307 Reduced 30.65%	478,177 $50 Million
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $143 Million - $249 Million	-2,626,700 Reduced 79.21%	689,484 $48.8 Million
Q2 2020 Aug 14, 2020	SELL	$29.67 - $80.0 $39.4 Million - $106 Million	-1,328,052 Reduced 28.6%	3,316,184 $213 Million
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $38.5 Million - $68.3 Million	2,162,732 Added 87.15%	4,644,236 $139 Million
Q4 2019 Feb 14, 2020	BUY	$13.93 - $21.28 $11 Million - $16.8 Million	787,469 Added 46.48%	2,481,504 $48.5 Million
Q3 2019 Nov 14, 2019	BUY	$12.26 - $18.07 $17.3 Million - $25.5 Million	1,413,059 Added 502.91%	1,694,035 $27 Million
Q2 2019 Aug 14, 2019	BUY	$13.7 - $28.34 $3.47 Million - $7.18 Million	253,421 Added 919.69%	280,976 $4.11 Million
Q1 2019 May 15, 2019	BUY	$14.45 - $23.7 $398,169 - $653,053	27,555 New	27,555 $561,000

Others Institutions Holding MRNA

# of Institutions

1,036

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.36M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $46.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account